Endeavor

New Trial Reveals Key Timing in Immunotherapy for Small Cell Lung Cancer

Adding immunotherapy after chemo-radiation may boost survival, but not during treatment

Moffitt Study Shows Promising Results for Treating Aggressive Prostate Cancer with Immunotherapy

New phase 2 trial explores adding nivolumab into combination treatment for advanced disease

AACR Cancer Progress Report Reveals Breakthroughs and Barriers

New therapies and research drive progress against cancer, but there’s still work to be done

Triplet Therapy Shows Promise in Advanced Lung Cancer

EVOKE-02 study marks an innovative and unconventional approach

Moffitt Celebrates Proton Therapy Unit Milestone at Speros

The topping out moment marks a major moment in Pasco campus’s construction

FDA Approval Brings New Standard of Care for Endometrial Cancer

Combination of immunotherapy and chemotherapy becomes new first line of defense

FDA Approves New Immunotherapy for Rare Blood Cancer

Lymphir offers a new option for patients with hard-to-treat cutaneous T-cell lymphoma

FDA Approves New Gene Therapy for Rare Soft Tissue Cancer

First-of-its-kind treatment offers new hope for adults with advanced synovial sarcoma

For These 2 Team Members, the Hope Behind Cell Therapies Is Personal

Alexander Dojcinovski and Jasmine Cherry are both now cancer free and working to cure others